KYNTRA BIO INC
KYNB · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $6.21
- Today’s Low
- $5.87
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $6.15
- Previous Close
- $6.12
- Volume
- 23.56K
- Market Cap
- $24.78M
- P/E Ratio
- 0.13X
- EPS
- $45.30
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 350 BAY STREET, SAN FRANCISCO, CA, UNITED STATES, 94133
- Country
- US
- Listing Date
- 2014-11-14
- Fiscal Year End
- December
- Shares Outstanding
- 4.05M
- CIK
- 0000921299
- Website
- www.kyntrabio.com/home
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is headquartered in San Francisco, California.
Financial Metrics
Revenue
2026-06-30
-$1.47M
2026-03-31
$3.73M
2025-12-31
$1.27M
2025-09-30
$1.07M
Operating Expenses
2026-06-30
$16.09M
2026-03-31
$13.45M
2025-12-31
$15.81M
2025-09-30
$6.31M
Net Income
2026-06-30
$11.97M
2026-03-31
-$15.19M
2025-12-31
$37.94M
2025-09-30
$148.47M
Net Profit Margin
2026-06-30
-812.34%
2026-03-31
-406.58%
2025-12-31
2.97K%
2025-09-30
13.79K%
Earnings Per Share
2026-06-30
$-4.68
2026-03-31
$-3.76
2025-12-31
$-3.51
2025-09-30
$49.61
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$49.48M
2026-03-31
-$12.69M
2025-12-31
-$20.95M
2025-09-30
-$10.87M
Effective Tax Rate
2026-06-30
0%
2026-03-31
-0.43%
2025-12-31
2.66%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -$1.47M | $3.73M | $1.27M | $1.07M |
| Operating Expenses | $16.09M | $13.45M | $15.81M | $6.31M |
| Net Income | $11.97M | -$15.19M | $37.94M | $148.47M |
| Net Profit Margin | -812.34% | -406.58% | 2.97K% | 13.79K% |
| Earnings Per Share | $-4.68 | $-3.76 | $-3.51 | $49.61 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$49.48M | -$12.69M | -$20.95M | -$10.87M |
| Effective Tax Rate | 0% | -0.43% | 2.66% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.